Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial [Gynecologic Cancer]
Conclusion
These results show that women who have severe menopausal symptoms after ovarian cancer treatment can safely take hormone-replacement therapy, and this may, in fact, infer benefits in terms of OS in addition to known advantages in terms of quality of life.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Eeles, Morden, Gore, Mansi, Glees, Wenczl, Williams, Kitchener, Osborne, Guthrie, Harper, Bliss Tags: Clinical Trials, Combined Modality, Menopausal Symptoms Gynecologic Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Epithelial Cancer | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Men | Menopause | OBGYN | Ovarian Cancer | Ovaries | Women